Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea.
Doubt has been expressed about the efficacy of nasal continuous positive airways pressure (NCPAP) therapy for sleep apnoea. Recent evidence from a randomized controlled trial of 1 month duration, suggested that NCPAP therapy can have a substantial impact on subjective and clinical outcomes in the sh...
Main Authors: | Jenkinson, C, Davies, R, Mullins, R, Stradling, JR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea.
by: Meston, N, et al.
Published: (2003) -
Is (re)titration of nasal continuous positive airway pressure for obstructive sleep apnoea necessary?
by: Choi, S, et al.
Published: (2001) -
Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.
by: Jenkinson, C, et al.
Published: (1999) -
Randomised, sham-placebo, parallel study of Nasal Continuous Positive Airway Pressure (NCPAP) for the treatment of Obstructive Sleep Apnoea (OSA)
by: Stradling, JR, et al.
Published: (1998) -
Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.
by: Pepperell, J, et al.
Published: (2002)